Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes

References

• Bars R. G., Mitchell A. M., Wolf C. R., Elcombe C. R. Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry. Biochemical Journal 1989; 262: 151–158
   PubMed Web of Science ®Google Scholar
• Breckenridge A., Orme M. L'E., Davies L., Thorgeirsson S. S., Davis D. S. Dose-dependent enzyme induction. Clinical and Pharmacological Therapeutics 1973; 14: 514–520
   PubMed Web of Science ®Google Scholar
• Chenery R. J., Ayrton A., Oldham H. G., Norman S. J., Standring P. The interaction of omeprazole with rat liver cytochrome P450-mediated monoxygenase reactions. in vitro and in vivo. Biochemical Pharmacology 1988; 37: 1407–1414
   PubMedGoogle Scholar
• Ciaccio P. J., Graves P. E., Bourque D. P., Glinsmann-Gibson B., Halpert J. R. cDNA and deduced amino acid sequences of dog liver cytochrome P-450 of the IIIA gene subfamily. Biochimica Biophysica Acta 1991; 1088: 319–322
   PubMed Web of Science ®Google Scholar
• Ciaccio P. J., Halpert J. R. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450 IIIA (steroid-inducible) gene subfamily. Archives of Biochemistry and Biophysics 1989; 271: 284–299
   PubMed Web of Science ®Google Scholar
• Diaz D., Fabre I., Daujat M., Aubert B. S., Bories P., Michel H., Maurel P. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P-450. Gastroenterology 1990; 99: 737–747
   PubMed Web of Science ®Google Scholar
• Duignan D. B., Sipes I. G., Ciaccio P. J., Halpert J. R. The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P-450 PBD-2. Archives of Biochemistry Biophysics 1988; 267: 294–304
   PubMed Web of Science ®Google Scholar
• Graves P. E., Elhag G. A., Ciaccio P. J., Bourque D. P., Halpert J. R. cDNA and amino acid sequences of a dog hepatic cytochrome P450IIB responsible for the metabolism of 2,2′,4,4′,5,5′-hexachlorobiphenyl. Archives of Biochemistry and Biophysics 1990; 281: 106–115
   PubMed Web of Science ®Google Scholar
• Holme J. A., SodÉRlund E., Dybing E. Drug metabolism activities of isolated rat hepatocytes in monolayer culture. Acta Pharmacologica et Toxicologica 1983; 52: 348–356
   PubMedGoogle Scholar
• Imaoka S., Terano Y., Funae Y. Constitutive testosterone 6β-hydroxylase in rat liver. Journal of Biochemistry 1988; 104: 481–487
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates. Journal of Pharmaceutics and Pharmacology 1975; 27: 739–746
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. The cytochrome P450I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug McTabolism Reviews 1990; 22: 1–85
   PubMed Web of Science ®Google Scholar
• Jauregui H. O., Ng S.-F., Gann K. L., Waxman D. J. Xenobiotic induction of P-450 PB-4 (IIB1) and P-450c (IA1) and associated monooxygenase activities in primary cultures of adult rat hepatocytes. Xenobiotica 1991; 21: 1091–1106
   PubMed Web of Science ®Google Scholar
• Kocarek T. A., Schuetz E. G., Guzelian P. S. Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. Molecular Pharmacology 1990; 38: 440–444
   PubMed Web of Science ®Google Scholar
• Komori M., Shimada H., Miura T., Kamataki T. Interspecies homology of liver microsomal cytochrome P-450. A form of dog cytochrome P-450 (P-450-D1) crossreactive with antibodies to rat P-450-male. Biochemical Pharmacology 1989; 38: 235–240
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Lan S. J., Weinstein S. H., Keim G. R., Migdalof B. H. Induction of hepatic drug-metabolizing enzymes in rats, dogs and monkeys after repeated administration of an antiinflammatory hexahydroindazole. Xenobiotica 1983; 13: 329–335
   PubMed Web of Science ®Google Scholar
• Lange R., Balny C., Maurel P. Inductive and repressive effects of rifampicin on rabbit liver microsomal cytochrome P-450. Biochemical Pharmacology 1984; 33: 2771–2776
   PubMedGoogle Scholar
• Lange R., Larroque C., Balny C., Maurel P. Isolation and partial characterization of a rifampicin induced rabbit liver microsomal cytochrome P-450. Biochemistry and Biophysics Research Communications 1985; 126: 833–839
   PubMedGoogle Scholar
• Lavrijsen K., Houdt J. V., Dyck D. V., Hendrickx J., Bockx M., Hurkmans R., Meuldermans W., Jeune L. L., Lauwers W., Heykants J. Comparative metabolism of flunarizine in rats, dogs and man: anin vitro study with subcellular liver fractions and isolated hepatocytes. Xenobiotica 1992; 22: 815–836
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maslansky C. J., Williams G. M. Primary cultures and the levels of cytochrome P-450-in hepatocytes from mouse, rat, hamster, and rabbit liver. In Vitro 1982; 18: 683–693
   PubMedGoogle Scholar
• Matsubara T., Otsubo S., Yoshihara E. Liver microsomal cytochrome P-450-dependent O-dealkylation reaction in various animals. Japanese Journal of Pharmacology 1983a; 33: 1065–1075
   PubMedGoogle Scholar
• Matsubara T., Otsubo S., Yoshihara E., Touchi A. Biotransformation of coamarin derivatives (2) oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and simple assay procedure for 7-alkoxycoumarinO-dealkylase. Japanese Journal of Pharmacology 1983b; 33: 41–56
   PubMedGoogle Scholar
• Matsubara T., Touchi A., Ogawa A. Heterogeneous distribution of the cytochrome P-450 monooxygenase system in rat liver lobes. Japanese Journal of Pharmacology 1982; 32: 999–1011
   PubMedGoogle Scholar
• McKillop D. Effects of phenobarbitone and β-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog. Biochemical Pharmacology 1985; 34: 3137–3142
   PubMedGoogle Scholar
• Michalopoulos G., Sattler C. A., Sattler G. L., Pitot H. C. Cytochrome P-450 induction by phenobarbital and 3-methylcholanthrene in primary cultures of hepatocytes. Science 1976; 193: 907–909
   PubMed Web of Science ®Google Scholar
• Miyazaki M., Handa Y., Oda M., Yabe T., Miyano K., Sato J. Long-term survival of functional hepatocytes from adult rat in the presence of phenobarbital in primary culture. Experimental Cell Research 1985; 159: 176–190
   PubMedGoogle Scholar
• Moldéus P., Högberg J., Orrenius S. Isolation and use of liver cells. Methods in Enzymology, S. Fleischer, L. Packer. Marcel Dekker, New York 1978; Vol. 52: 60–71
   Google Scholar
• Morel F., Beaune P. H., Ratanasavanh D., Flinois J. P., Yang C. S., Guengerich F. P., Guillouzo A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. European Journal of Biochemistry 1990; 191: 437–444
   PubMedGoogle Scholar
• Namiki M., Degawa M., Masuko T., Hashimoto Y. Changes in the quantity and activity of cytochrome P-450 isosymes in primary cultured rat hepatocytes. Japanese Journal of Cancer Research 1989; 80: 126–131
   PubMedGoogle Scholar
• Niemann C., Gauthier J. C., Richert L., Ivanov M. A., Melcion C., Cordier A. Rat adult hepatocytes in primary pure and mixed monolayer culture. Comparison of the maintenance of mixed function oxidase and conjugation pathways of drug metabolism. Biochemical Pharmacology 1991; 42: 373–379
   PubMedGoogle Scholar
• Okuno H., Nakanishi S., Kitao Y., Takasu M., Murase T., Shiozaki Y., Sameshima Y. Comparison of the effects of various inducers on 7-alkoxycoumarinO-dealkylase activities in liver microsomes. Japanese Journal of Pharmacology 1989; 50: 1–9
   PubMedGoogle Scholar
• Paine A. J. The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chemical-Biological Interactions 1990; 74: 1–31
   PubMed Web of Science ®Google Scholar
• Parke B. K., Breckenridge A. M. Clinical implications of enzyme induction and enzyme inhibition. Clinical Pharmacokinetics 1981; 6: 1–24
   PubMed Web of Science ®Google Scholar
• Parke D. V. The endoplasmic reticulum: its role in physiological functions and pathological situations. Concepts in Drug Metabolism, Part B, P. Jenner, B. Testa. Marcel Dekker, New York 1981; 1–52
   Google Scholar
• Pasco D. S., Boyum K. W., Merchant S. N., Chalberg S. C., Fagan J. B. Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P-450c and P450din vivo and in primary hepatocyte cultures. Journal of Biological Chemistry 1988; 263: 8671–8676
   PubMed Web of Science ®Google Scholar
• Shiraga T., Iwasaki K. Purification and characterization of cytochrome P-450 from liver microsomes of beagle dogs. Journal of Pharmacobio-Dynamics 1991; 14: s50
   Google Scholar
• Sogawa K., Gotoh O., Kawajiri K., Fujii-Kuriyama Y. Distinct organization of methylcholanthrene- and phenobarbital-inducible cytochrome P-450 gene in the rat. Proceedings of the National Academy of Sciences, USA 1984; 81: 5066–5070
   PubMed Web of Science ®Google Scholar
• SouĆEk P., Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 1992; 22: 83–103
   PubMed Web of Science ®Google Scholar
• Swinney D. C. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5α-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog and rat. Drug Metabolism and Disposition 1990–1990; 18: 859–865
   PubMed Web of Science ®Google Scholar
• Testa B., Jenner P. Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metabolism Reviews 1981; 12: 1–117
   PubMed Web of Science ®Google Scholar
• Tong J. Z., De Lagausie P., Furlan V., Cresteil T., Bernard O., Alvarez F. Long-term culture of adult rat hepatocyte spheroids. Exprimental Cell Research 1992; 200: 326–332
   PubMed Web of Science ®Google Scholar
• Uchida T., Komori M., Kitada M., Kamataki T. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs. Molecular Pharmacology 1990; 38: 644–651
   PubMed Web of Science ®Google Scholar
• Vukicevic S., Kleinman H. K., Luyten F. P., Roberts A. B., Roche N. S., Reddi A. H. Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Experimental Cell Research 1992; 202: 1–8
   PubMed Web of Science ®Google Scholar
• Warren M., Fry J. R. Influence of medium composition of 7-alkoxycoumarinO-dealkylase activities of rat hepatocytes in primary maintenance culture. Xenobiotica 1988; 18: 973–981
   PubMed Web of Science ®Google Scholar
• Waxmann D. J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry 1983; 258: 11937–11947
   PubMedGoogle Scholar
• Waxman D. J., Morrissey J. J., Naik S., Jauregui H. O. Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. Biochemical Journal 1990; 271: 113–119
   PubMed Web of Science ®Google Scholar